All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @lf.fitness.n.pharma on TikTok · 284s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @lf.fitness.n.pharma's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:02That's my foot tapping.
  2. 0:04Down faces, I'm in the best place.
  3. 0:07What's going on ya fucking bitties.
  4. 0:09Today we're gonna be going through a extensive overview on my personal experience with
  5. 0:14SEMA Glutide. What is SEMA Glutide? It is the most effective fat loss product ever created,
  6. 0:20hands down, second to none. Period. End of story.
  7. 0:24I think you did a yellow that I painted.
  8. 0:28GLP1 Agonist. It'll help you lose weight, three different capacities, glucose control,
  9. 0:33insulin resistance, as well as ghrelin blockage.
  10. 0:35Ghrelin blockage being the hunger hormone, so it makes you, you're literally not hungry.
  11. 0:39For 100 people taking it right now, and I'm coaching personally.
  12. 0:45How many are getting results? Very fucking one of them.
  13. 0:48Do I take it? Yep, you guys know that I take it and just started it in four weeks ago.
  14. 0:53K-Towns taking it too. She's getting results like a motherfucker.
  15. 0:57Fuck K-Town. We're gonna be talking about me.
  16. 1:00Feels about me.
  17. 1:01So guys, first payment in 0.25 milligrams.
  18. 1:04First week, my first seven days on that 0.25.
  19. 1:08Pretty minimal. It's pretty minimal.
  20. 1:10Notice a slight hunger decrease. That was about it.
  21. 1:14The second week I actually took off because I had an event.
  22. 1:17I didn't want to feel nauseous at the event, so I decided not to take it.
  23. 1:22And then I've been on it steady now for the last two weeks at 0.5.
  24. 1:26Now it's doing something.
  25. 1:29And I gotta say, I'm impressed.
  26. 1:32nausea is a very common side effect to this drug.
  27. 1:35And you know, for many people it fades away over time.
  28. 1:38I cannot say that I feel nauseous.
  29. 1:40I don't feel nauseous. Like not all the time.
  30. 1:42I'm a fat kid in here. I love to eat.
  31. 1:45And the last of all of us packed in away 60,000 calories.
  32. 1:49And it was awesome because I love to eat.
  33. 1:51Things from that to where I'm at now on an average date.
  34. 1:55Guys, I'm probably taking about 1,800 calories.
  35. 2:00Weird thing about it though, I feel satiated.
  36. 2:03Like it's really weird.
  37. 2:05Like, I'm halfway done my meal.
  38. 2:07And I'll just feel like full.
  39. 2:10And I've pushed the limits a few times because the food is real good.
  40. 2:14I was like, I don't want to finish this.
  41. 2:15I don't want to waste it.
  42. 2:17And I regret it every time.
  43. 2:20Few times I was puked up my food
  44. 2:22because it just makes you feel fucking ill if you eat too much.
  45. 2:26Interrupting my video time.
  46. 2:29Or damn it!
  47. 2:30Kristen's reading my beer French.
  48. 2:32I'm telling.
  49. 2:33It's between eating and interacting.
  50. 2:36Do you have to go to work in like an hour?
  51. 2:40Anywho, that's two weeks.
  52. 2:41I've been consistent with the .5 guys.
  53. 2:43Where's it goes?
  54. 2:44I haven't noticed any other side effect besides the inability
  55. 2:48to eat large quantities of food.
  56. 2:50And I'm just less hungry.
  57. 2:52Less cravings.
  58. 2:52Like I'm a fucking cookie monster, guys.
  59. 2:54Like that is my kryptonite.
  60. 2:56So don't tell anyone.
  61. 2:58Okay, he's sitting right up there on the counter right now.
  62. 3:00And I walk by him every day.
  63. 3:02Don't even touch him.
  64. 3:02And that's like, I don't know if you guys understand the power,
  65. 3:06the relevance behind that, but that's saying a lot.
  66. 3:09Because I go balls deep and then cookies.
  67. 3:11When I started the SEMA, I had I had re-comped quite crazy
  68. 3:16with the animal or L or three.
  69. 3:18Started the SEMA.
  70. 3:19Guys, I'm down.
  71. 3:20I was 2.17 when I started doing the SEMA efficiently guys.
  72. 3:24I'm down to 209 pounds.
  73. 3:26That's like call it.
  74. 3:27I don't call it two weeks.
  75. 3:31Effectively two weeks on it.
  76. 3:34I did start it four weeks ago, but I missed the one dose.
  77. 3:36You guys know the story.
  78. 3:38Anyways, guys, I will leave it at that.
  79. 3:39If you guys did not know,
  80. 3:40SEMA Glutide is an injectable peptide.
  81. 3:43It goes under the skin or into your belly fat.
  82. 3:45It is super, super easy to dose, one injection a week.
  83. 3:49Any questions about the compound or my experience?
  84. 3:51Please do not hesitate to reach out on Instagram.
  85. 3:53I'd love to help.
  86. 3:54The source is SEMA Glutide.
  87. 3:55You can go check the comments.
  88. 3:57Unfortunately, the triggered website is down as the hosting was pulled,
  89. 4:00but the website should be back up shortly.
  90. 4:03If you're a Russian cunt and you want to get an order in,
  91. 4:06you can place an order manually.
  92. 4:07Just DM me and I'll send you the Google form
  93. 4:09that you need to fill out to do so.
  94. 4:11If you fucking idiots need coaching and offer that for
  95. 4:14as little as two bucks a day, hit me up on Instagram.
  96. 4:17If you guys don't want coaching,
  97. 4:18you just want a fucking quick little info call.
  98. 4:21I offer those 50 bucks pace.
  99. 4:22Unsalt, motherfucker.
  100. 4:24For a memory of a Canadian's, I'm not a doctor.
  101. 4:27Although I know more than your doctor, I'm not a doctor.
  102. 4:30I do not have a 200,000 or $300,000 certificate
  103. 4:34that says that I went to school.
  104. 4:35So do not listen to me.
  105. 4:37This video is only for entertainment purposes.
  106. 4:39That's it for last one.
  107. 4:40You have fucking idiots.

Kelland Chaffee's semaglutide claims need more context

Kelland Chaffee

TikTok creator

16.3K viewsWatch on TikTok

Quick answer

The creator describes a self-directed semaglutide titration starting at 0.25 mg weekly and escalating to 0.5 mg, consistent with the standard initiation protocol, but administered without documented medical supervision or baseline metabolic screening. He reports an 8-pound reduction over approximately two weeks of consistent dosing, a plausible but unverified outcome that conflates subcutaneous fat loss with total weight change including fluid shifts. The video also promotes purchasing semaglutide through an unregulated third-party source, which bypasses the safety evaluations required before prescribing GLP-1 receptor agonists, including assessment for contraindications such as personal or family history of medullary thyroid carcinoma.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksSemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Kelland Chaffee's semaglutide claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Kelland Chaffee's semaglutide claims need more context" from Kelland Chaffee. We read the clip as a GLP-1 social video fact-checks claim about Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes a self-directed semaglutide titration starting at 0.

The reason this review is not generic is the source wording and the canonical claim label "glp1 my personal experience taking semaglutide for the past 4 wee." In this clip, the useful excerpt is: "That's my foot tapping." That wording changes the review because it points to Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Tirzepatide showed up to 22.
People who land here are usually comparing the Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes a self-directed semaglutide titration starting at 0.

FormBlends verdict

Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes a self-directed semaglutide titration starting at 0.25 mg weekly and escalating to 0.5 mg, consistent with the standard initiation protocol, but administered without documented medical supervision or baseline metabolic screening. He reports an 8-pound reduction over approximately two weeks of consistent dosing, a plausible but unverified outcome that conflates subcutaneous fat loss with total weight change including fluid shifts. The video also promotes purchasing semaglutide through an unregulated third-party source, which bypasses the safety evaluations required before prescribing GLP-1 receptor agonists, including assessment for contraindications such as personal or family history of medullary thyroid carcinoma.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) found a mean 14.9% body weight reduction with semaglutide 2.4 mg over 68 weeks, making it clinically significant but not categorically superior to all other options.
  • Tirzepatide showed up to 22.5% mean weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM), directly contradicting the 'best fat loss product ever' claim.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Semaglutide

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) found a mean 14.9% body weight reduction with semaglutide 2.4 mg over 68 weeks, making it clinically significant but not categorically superior to all other options.
  • Tirzepatide showed up to 22.5% mean weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM), directly contradicting the 'best fat loss product ever' claim.
  • GLP-1 receptor agonists suppress appetite primarily through hypothalamic receptors and gastric emptying delay, not direct ghrelin receptor blockade as the creator implies.
  • The STEP 4 trial (Rubino et al., 2021, JAMA) demonstrated significant weight regain after semaglutide discontinuation, a long-term consideration the video does not address.
  • FDA prescribing information for semaglutide lists contraindications including personal or family history of medullary thyroid carcinoma and MEN2 syndrome, which cannot be screened for without a medical consultation.
  • Purchasing semaglutide from unregulated online sources carries risks of unknown concentration, contamination, and counterfeit product with no FDA oversight.
  • Vomiting after overeating on semaglutide, as the creator describes, reflects the drug's gastric emptying mechanism and is a documented adverse effect of dose-inappropriate food intake, not a sign the medication is working optimally.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @lf.fitness.n.pharma actually say?

The creator described four weeks of personal semaglutide use, starting at 0.25 mg then moving to 0.5 mg, and reported dropping from 217 to 209 pounds. He called semaglutide "the most effective fat loss product ever created, hands down" and claimed it works through "glucose control, insulin resistance, as well as ghrelin blockage." He also admitted to vomiting after overeating on the drug, skipping a dose before an event to avoid nausea, and feeling full at around 1,800 calories per day. Toward the end of the video, he directed viewers to a now-offline website to purchase semaglutide and offered coaching for "two bucks a day." He closed with a disclaimer that he is not a doctor and the video is for entertainment only.

Does the science back this up?

The general weight loss mechanism he describes is mostly in the right ballpark, but the "ghrelin blockage" claim is where the science gets complicated. Semaglutide is a GLP-1 receptor agonist, and its primary mechanisms involve slowing gastric emptying, stimulating insulin secretion in a glucose-dependent manner, and acting on hypothalamic appetite centers. It does reduce hunger, but calling this "ghrelin blockage" is an oversimplification that conflates two different hormone systems.

GLP-1 receptor agonists primarily suppress appetite through central nervous system receptors and by slowing gastric emptying, not by directly blocking ghrelin receptors. Blomain et al. (2016, ISRN Obesity) noted that ghrelin suppression seen during GLP-1 therapy is likely an indirect downstream effect, not the primary mechanism. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) confirmed an average 14.9% body weight reduction over 68 weeks at the 2.4 mg maintenance dose in non-diabetic adults. His two-week results are plausible, though early losses often reflect water weight and glycogen depletion rather than fat mass alone.

What did they get wrong (or right)?

Credit where it is due: the creator accurately described the standard titration schedule, the once-weekly subcutaneous injection method, and the reality that nausea is common but often fades. Reporting early results honestly, including vomiting from overeating, is more transparent than most semaglutide content on TikTok.

What he got wrong, or at least oversimplified, is real. Calling semaglutide "the most effective fat loss product ever created, period, end of story" is not a clinical position. It ignores patient variability, contraindications for people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome (FDA label, Ozempic, 2023), and the reality that roughly 5 to 10 percent of trial participants are non-responders (Davies et al., 2021, The Lancet). His claim that "every fucking one" of his 100 clients is getting results is unverifiable and almost certainly false by the statistical baseline alone. The "ghrelin blockage" framing, while not entirely wrong directionally, misrepresents the actual pharmacology. Directing viewers to purchase semaglutide from a personal website with no medical oversight is a serious safety and regulatory concern that his entertainment disclaimer does not cover.

What should you actually know?

Semaglutide is a legitimate, FDA-approved medication, but it is not a supplement you order from someone's Google form. Semaglutide is approved under brand names Ozempic and Wegovy and requires a prescription because it carries real risks: pancreatitis, gallbladder disease, potential thyroid C-cell tumor risk in animal models, and significant drug interactions. Buying it from an unregulated source means you have no certainty about the concentration, sterility, or even what compound is actually in the vial.

The weight loss results he describes are consistent with clinical data for the early titration phase, but eight pounds in two weeks on a low starting dose is not representative of typical long-term outcomes. The STEP 4 trial (Rubino et al., 2021, JAMA) also showed that weight rebounds when the drug is discontinued, something the creator does not mention. If you are considering semaglutide for weight management, that conversation starts with a licensed clinician who can review your medical history, not a TikTok comment section.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Kelland Chaffee · TikTok creator

16.3K views on this video

My Personal Experience taking Semaglutide for the past 4 weeks... . well... kinda... . #bodybuilding #bodybuildingmotivation #fitness #fitnessmotivation #semaglutide #fatloss #fyp

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) found?

The STEP 1 trial (Wilding et al., 2021, NEJM) found a mean 14.9% body weight reduction with semaglutide 2.4 mg over 68 weeks, making it clinically significant but not categorically superior to all other options.

What does the video say about tirzepatide showed up to 22.5% mean weight loss in surmount-1?

Tirzepatide showed up to 22.5% mean weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM), directly contradicting the 'best fat loss product ever' claim.

What does the video say about glp-1 receptor agonists suppress appetite primarily through hypothalamic receptors?

GLP-1 receptor agonists suppress appetite primarily through hypothalamic receptors and gastric emptying delay, not direct ghrelin receptor blockade as the creator implies.

What does the video say about the step 4 trial (rubino et al., 2021, jama) demonstrated?

The STEP 4 trial (Rubino et al., 2021, JAMA) demonstrated significant weight regain after semaglutide discontinuation, a long-term consideration the video does not address.

What does the video say about fda prescribing information for semaglutide lists contraindications including personal?

FDA prescribing information for semaglutide lists contraindications including personal or family history of medullary thyroid carcinoma and MEN2 syndrome, which cannot be screened for without a medical consultation.

What does the video say about purchasing semaglutide from unregulated online sources carries risks of unknown?

Purchasing semaglutide from unregulated online sources carries risks of unknown concentration, contamination, and counterfeit product with no FDA oversight.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Kelland Chaffee, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.